PDPN and cancer: The anti-PDPN antibodies NZ-1 and NZ-8 induce antibody- and complement-dependent cellular cytotoxicity, resulting in the removal of cancer cells and the suppression of TCIPA, tumor growth, and tumor metastases [20].